BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 44 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,567,480 | +131.0% | 16,561,000 | +87.6% | 0.00% | +100.0% |
| Q2 2023 | $5,440,257 | -0.2% | 8,827,000 | +3.5% | 0.00% | 0.0% |
| Q1 2023 | $5,452,079 | +33.6% | 8,527,000 | -19.0% | 0.00% | +100.0% |
| Q4 2022 | $4,082,371 | -7.0% | 10,527,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,389,000 | +3.0% | 10,527,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,263,000 | -6.0% | 10,527,000 | +10.5% | 0.00% | 0.0% |
| Q1 2022 | $4,533,000 | – | 9,527,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 52,257,000 | $39,745,106 | 8.72% |
| Context Capital Management, LLC | 32,083 | $24,052 | 1.93% |
| BRAIDWELL LP | 67,294,000 | $50,470,500 | 1.60% |
| DeepCurrents Investment Group LLC | 17,855,000 | $13,514,056 | 0.59% |
| Aequim Alternative Investments LP | 20,000,000 | $15,000,000 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,488,000 | $22,116,000 | 0.51% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $3,750,375 | 0.51% |
| ARISTEIA CAPITAL, L.L.C. | 25,280,000 | $18,960,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 8,217,000 | $6,121,665 | 0.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,604,000 | $3,430,520 | 0.49% |